SEC Form 4 · accession 0001185185-16-005983
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 5:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Nov 14, 2016 | G | 2,000 | $0.00 | D | 249,000 | D | |
| Common stock | Nov 18, 2016 | G | 2,000 | $0.00 | D | 247,000 | D | |
| Common stock | Nov 25, 2016 | G | 2,000 | $0.00 | D | 245,000 | D | |
| Common stock | Dec 2, 2016 | G | 2,000 | $0.00 | D | 243,000 | D | |
| Common stock | Dec 9, 2016 | G | 2,000 | $0.00 | D | 241,000 | D | |
| Common stockF1 | Dec 15, 2016 | A | 150,000 | $0.00 | A | 391,000 | D | |
| Common stock | Dec 16, 2016 | G | 2,000 | $0.00 | D | 389,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock awarded pursuant to the Issuer's 2008 Omnibus Incentive Plan.
Remarks
THIS FORM 4 IS A CONTINUATION OF THE FORM 4 FILE IMMEDIATELY PRIOR. THE FILINGS WERE SEPARATED DUE TO INSUFFICIENT ROOM ON THE FIRST FILING TO SUPPLY ALL OF THE DATA.